Back To Rising Leaders Gallery
Treatments for bacterial vaginosis have two main drawbacks: they are based on antibiotics, and they are largely ineffective at preventing...
Gedea Champions Both Women’s Health And The Fight Against Antibiotic Resistance
Exclusive Interview With CEO Annette Säfholm
Gedea Biotech is developing an antibiotic-free drug which could significantly improve the treatment of bacterial vaginosis. In Vivo spoke with CEO Annette Säfholm, a 2021 Rising Leader.
